Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study-Reference-Cited by-同舟云学术

Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study

Author:

Ghosh Shibaji¹²³⁴⁵,Jana Kalyanashis¹²³⁴⁵^ORCID,Ganguly Bishwajit¹²³⁴⁵^ORCID

Affiliation:

1. Computation and Simulation Unit (Analytical and Environmental Science Division and Centralized Instrument Facility)

2. CSIR-Central Salt and Marine Chemicals Research Institute

3. Bhavnagar

4. India

5. Academy of Scientific and Innovative Research

Abstract

Donepezil, an acetylcholinesterase inhibitor, is an approved drug for the symptomatic treatment of Alzheimer's disease (AD).

Funder

University Grants Commission

Department of Science and Technology, Ministry of Science and Technology

Department of Biotechnology, Ministry of Science and Technology

Council of Scientific and Industrial Research, India

Board of Research in Nuclear Sciences

Publisher

Royal Society of Chemistry (RSC)

Subject

Physical and Theoretical Chemistry,General Physics and Astronomy

Link

Reference51 articles.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献